E. Raefsky

发表

Tracheoesophageal (TE) fistula development in a phase II trial of concurrent chemoradiation (CRT) and bevacizumab (B) in limited-stage small-cell lung cancer (LS-SCLC)

J. Hainsworth, L. Hart, H. Burris, 2008 .

Phase I Study of JM-216 (an Oral Platinum Analogue) in Combination with Paclitaxel in Patients with Advanced Malignancies

Suzanne F. Jones, J. Hainsworth, H. Burris, 2002, Investigational New Drugs.

Bevacizumab and erlotinib in the treatment of patients with metastatic renal carcinoma (RCC): Update of a phase II multicenter trial

J. Hainsworth, J. Sosman, K. Yost, 2005 .

Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone‐refractory prostate carcinoma

J. Hainsworth, F. Greco, R. Steis, 2003, Cancer.

Adjuvant dose-intense chemotherapy with peripheral blood stem cell support in stage II-III breast cancer with five to nine involved axillary lymph nodes.

J. Hainsworth, B. McAneny, F. Greco, 1999, American journal of clinical oncology.

Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: outcomes by intent to treat analyses

J. Hainsworth, B. McAneny, F. Greco, 1997, Bone Marrow Transplantation.

Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first‐line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma

J. Hainsworth, D. Spigel, F. Greco, 2008, Cancer.

Biological and immunological characterization of ATG and ALG

N. Young, A. Gratwohl, B. Speck, 1986 .

Preliminary Results of a Phase II Trial of Panobinostat (LBH589) In Refractory Myelodysplastic Syndromes (MDS) Patients

I. Flinn, J. Hainsworth, H. Burris, 2010 .

Neutropenia associated with large granular lymphocytes responsive to corticosteroids in vitro and in vivo

N. Young, L. Platanias, E. Raefsky, 1987, European journal of haematology.

Biological and immunological characterization of ATG and ALG.

N. Young, A. Gratwohl, B. Speck, 1986, Blood.

Biological and immunological characterization of ATG and ALG.

N. Young, A. Gratwohl, B. Speck, 1986, Blood.

Lymphokines and hematopoiesis.

N. Zoumbos, N. Young, E. Raefsky, 1986, Progress in hematology.

Paclitaxel administered by a 1-hour infusion: A phase I-II trial comparing two schedules.

J. Hainsworth, F. Greco, E. Raefsky, 1995, The cancer journal from Scientific American.

Prolonged intermittent oral topotecan in patients with refractory and/or advanced malignancies

Suzanne F. Jones, J. Hainsworth, H. Burris, 2004 .

Studies of interferon as a regulator of hematopoietic cell proliferation.

N. Young, L. Platanias, N. Zoumbos, 1985, Journal of immunology.

Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia

N. Young, A. Nienhuis, E. Leonard, 1989, British journal of haematology.

Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast cancer: outpatient administration in community cancer centers.

J. Hainsworth, F. Greco, L. Campos, 1998, American journal of clinical oncology.

Rituximab with or without bevacizumab for the treatment of patients with relapsed follicular lymphoma.

J. Reeves, I. Flinn, J. Hainsworth, 2014, Clinical lymphoma, myeloma & leukemia.

Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy for resected nonsmall cell lung carcinoma

J. Hainsworth, H. Burris, F. Greco, 2001, Cancer.

Amrubicin as second- or third-line treatment for women with metastatic HER2-negative breast cancer: a Sarah Cannon Research Institute phase 1/2 trial

J. Hainsworth, H. Burris, D. Yardley, 2014, Breast Cancer Research and Treatment.

Phase II study of NK012 in relapsed small cell lung cancer.

J. Hainsworth, J. Bendell, H. Burris, 2011, Journal of Clinical Oncology.

Irinotecan, carboplatin, and imatinib in extensive stage small cell lung cancer: A phase II trial of the Minnie Pearl Cancer Research Network.

J. Hainsworth, H. Burris, D. Yardley, 2004, Journal of Clinical Oncology.

Day 1 pegfilgrastim with dose dense adjuvant chemotherapy: Amelioration of docetaxel neutropenia but not that of doxorubicin/cyclophosphamide. Results from a Sarah Cannon Research Institute pilot study

J. Hainsworth, H. Burris, D. Yardley, 2005 .

Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site

J. Hainsworth, K. Yost, D. Spigel, 2005, Cancer.

A phase I trial of protracted oral fixed‐dose temozolomide

Suzanne F. Jones, J. Hainsworth, F. Greco, 2005, Cancer.

Long-Term Followup of Patients with Follicular Lymphoma (FL) Treated with Two Years of Maintenance Rituximab: Response to Rituximab Retreatment at Progression.

J. Hainsworth, D. Spigel, F. Greco, 2006 .